Finance

Lists
FBLG:NASDAQ
Fibrobiologics Inc
$1.44
-7.10%
(-0.11) 1D
$1.55
+7.64% (+0.11)
Pre-market
Closed: Sep 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBLG...
Open
$1.55
High
$1.58
Low
$1.44
Mkt. cap
9.59M
Avg. vol.
307.03K
Volume
265.00
52-wk high
$12.40
52-wk low
$0.62
EPS
-$5.74
Shares outstanding
6.66M
No. of employees
15
Open
$1.55
High
$1.58
Low
$1.44
Mkt. cap
9.59M
Avg. vol.
307.03K
Volume
265.00
52-wk high
$12.40
52-wk low
$0.62
EPS
-$5.74
Shares outstanding
6.66M
No. of employees
15
News stories
From web sources and news partners
About Fibrobiologics Inc
CEO-
Employees15
Founded2021
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitefibrobiologics.com
Analyst ratings
Based on 1 analyst giving stock ratings to FBLG in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for FBLG in the last 3 months
Highest
Current $1.44
$6.00 (+316.67%)
Average
$6.00 (+316.67%)
Lowest
$6.00 (+316.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Maintained
$6.00
+316.7%
08/04/2026
Michael Okunewitch
Maxim Group
Hold
Downgraded
-
-
05/04/2026
Jason Kolbert
D. Boral Capital
Hold
Downgraded
-
-
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.79M
797.00K
2.95M
1.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.25M
1.79M
2.12M
2.38M
Operating expense
5.04M
2.59M
5.07M
4.03M
Total operating expenses
5.04M
2.59M
5.07M
4.03M
Operating income
-5.04M
-2.59M
-5.07M
-4.03M
Other non operating income
-813.00K
-475.00K
54.00K
-92.00K
EBT including unusual items
-5.78M
-3.24M
-5.00M
-4.12M
EBT excluding unusual items
-5.78M
-3.24M
-5.00M
-4.12M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.78M
-3.24M
-5.00M
-4.12M
Net profit margin
-
-
-
-
Earnings per share
-2.60
-0.60
-1.33
-0.66
Interest and investment income
73.00K
25.00K
20.00K
15.00K
Interest expense
-
-204.00K
-4.00K
-7.00K
Net interest expenses
73.00K
-179.00K
16.00K
8.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.97M
-2.52M
-5.00M
-3.97M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps